Kineta Inc (KANT)

OTC Markets
Currency in USD
0.2974
-0.0023(-0.77%)
Closed·
KANT Scorecard
Full Analysis
Stock generally trades with high price volatility
KANT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.29390.2974
52 wk Range
0.19211.1500
Key Statistics
Edit
Prev. Close
0.2997
Open
0.2939
Day's Range
0.2939-0.2974
52 wk Range
0.1921-1.15
Volume
1.13K
Average Volume (3m)
13.73K
1-Year Change
-46.3%
Book Value / Share
-0.98
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KANT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Kineta Company Profile

Kineta, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies that transform patients’ lives in the United States. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, renal cell carcinoma, head and neck, renal cell, and colorectal cancers. It also developing anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. It has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., Merck &Co., Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. is headquartered in Mercer Island, Washington.

Compare KANT to Peers and Sector

Metrics to compare
KANT
Peers
Sector
Relationship
P/E Ratio
−0.2x−2.9x−0.5x
PEG Ratio
0.020.000.00
Price/Book
−0.3x1.9x2.6x
Price / LTM Sales
-14.1x2.9x
Upside (Analyst Target)
-229.9%50.4%
Fair Value Upside
Unlock8.9%9.1%Unlock

Earnings

Latest Release
Mar 06, 2025
EPS / Forecast
-0.27 / -0.24
Revenue / Forecast
-- / 300.00K
EPS Revisions
Last 90 days

FAQ

What Is the Kineta (KANT) Stock Price Today?

The Kineta stock price today is 0.30.

What Stock Exchange Does Kineta Trade On?

Kineta is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Kineta?

The stock symbol for Kineta is "KANT."

What Is the Kineta Market Cap?

As of today, Kineta market cap is 3.65M.

What Is Kineta's Earnings Per Share (TTM)?

The Kineta EPS (TTM) is -1.42.

From a Technical Analysis Perspective, Is KANT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.